|
|
 |
|
Viewing report
|
|
|
|
IMPAX Laboratories, Inc. (IPXL) - Financial and Strategic SWOT Analysis Review
GlobalData, March 2012, Pages: 43
IMPAX Laboratories, Inc. (IPXL) - Financial and Strategic SWOT Analysis Review
Summary
IMPAX Laboratories, Inc. (Impax) is a publicly traded, technology based specialty pharmaceutical company developing, manufacturing and marketing generic and branded pharmaceuticals. The company develops its pharmaceuticals with the help of controlled release, development and formulation expertise. The company focuses on controlled release generic versions of a few branded pharmaceuticals to target a range of therapeutic areas. Its branded products are aimed for the treatment of disorders related to the central nervous system. Impax operates its business in two segments, namely, Impax Pharmaceutical and Global Pharmaceuticals. The company is headquartered in Hayward, California, the US.
IMPAX Laboratories, Inc. Key Recent Developments
Feb 28, 2012: Impax Laboratories Adopts Revitas’s Suite
Feb 28, 2012: Impax Laboratories Reports Revenue Of $158.6m In Q4 2011
Feb 09, 2012: Impax Provides Update On Status Of Warning Letter Resolution For Hayward Facility
Jan 23, 2012: Perrigo Confirms Filing For Generic Version Of Astepro Nasal Spray
Dec 22, 2011: Veloxis Pharmaceuticals Announces Settlement Of Impax Patent Litigation
This comprehensive SWOT profile of IMPAX Laboratories, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
IMPAX Laboratories, Inc. - Product Pipeline Review - H2 2011
IMPAX Laboratories, Inc. - Product Pipeline Review - Q1 2011
Perrigo Company (PRGO) - Financial and Strategic SWOT Analysis Review
Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review
Mylan Inc. (MYL) - Financial and Strategic SWOT Analysis Review
GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review
Avanir Pharmaceuticals, Inc. (AVNR) - Financial and Strategic SWOT Analysis Review
Forest Laboratories, Inc. (FRX) - Financial and Strategic SWOT Analysis Review
IMPAX Laboratories, Inc. - Product Pipeline Review - Q4 2010
Valeant Pharmaceuticals International, Inc. (VRX) - Financial and Strategic SWOT Analysis Review
|
|
|
|
